Sirous Zeinali - Genetic Mutations

Author Information

Dr. Sirous Zeinali is a prominent researcher affiliated with the Medical Genetics Laboratory at the Kawsar Human Genetics Research Center, located in Tehran, Iran. His research primarily focuses on the field of genetics, with a particular emphasis on molecular diagnostics and genetic disorders. Dr. Zeinali has significantly contributed to the understanding of genetic determinants and their applications in medical genetics, particularly within the context of precision medicine.

Research Contributions

Dr. Zeinali's research contributions are diverse and impactful, covering various aspects of genetics and molecular biology. He has extensively worked on preimplantation genetic diagnosis and screening for beta-thalassemia, cystic fibrosis, and other genetic disorders. His work on the modulation of IL-2 interactions and the inhibitory effects of miRNA on cancer cell lines highlights his involvement in both computational and experimental approaches to understanding disease mechanisms. Additionally, his research includes the identification and analysis of novel genetic mutations and their implications, particularly in the Iranian population.

Aliases

Dr. Sirous Zeinali is known in academic circles by several aliases including S Zeinali and S. Zeinali. These variations are often used interchangeably in publications and citations.

Publication and Citation Metrics

Metric	Value
Total Citation Count	3746
h-index	29
Total Number of Papers	308

Publications:

A decade of molecular preimplantation genetic diagnosis of 350 blastomeres for beta-thalassemia combined with HLA typing, aneuploidy screening and sex selection in Iran

DOI: 10.1186/s12884-022-04660-9

Year: 2022

Human IL-2Rɑ subunit binding modulation of IL-2 through a decline in electrostatic interactions: A computational and experimental approach

DOI: 10.1371/journal.pone.0264353

Year: 2022

Whole-transcriptome sequencing-based concomitant detection of viral and human genetic determinants of cutaneous lesions.

DOI: 10.1172/jci.insight.156021

Year: 2022

Reporting two novel mutations in two Iranian families with cystic fibrosis, molecular and bioinformatic analysis.

DOI:

Year: 2022

Recalcitrant Cutaneous Warts in a Family with Inherited ICOS Deficiency.

DOI: 10.1016/j.jid.2022.02.011

Year: 2022

Inhibitory Effect of miRNA-145 on PD-L1 Expression in Breast Cancer Cell Line

DOI: 10.30699/ijbd.14.4.45

Year: 2022

Ichthyosis follicularis syndromes in patients with germline mutations in GJB2.

DOI: 10.1111/ced.15217

Year: 2022

Efficacy and antitumor activity of a mutant type of interleukin 2

DOI: 10.1038/s41598-022-09278-7

Year: 2022

Very-Early-Onset Inflammatory Bowel Disease in a Patient With Junctional Epidermolysis Bullosa With a Homozygous Mutation in the α6 Integrin Gene (ITGA6).

DOI: 10.1093/ibd/izab141

Year: 2021

Whole-Transcriptome Analysis by RNA Sequencing for Genetic Diagnosis of Mendelian Skin Disorders in the Context of Consanguinity.

DOI: 10.1093/clinchem/hvab042

Year: 2021

What is Polyploidy?

What is Cystic Fibrosis (CF)?

What is Occupational Therapy?

Can Immunotherapy Cause Genetic Mutations?

What is Benzene?

Why is Sequencing Important for Studying Genetic Mutations?

How are Missense Mutations Detected?

Are There Treatments Available for Genetic Mutation-Related Infertility?

Are Synonymous Mutations Considered in Genetic Research?

What Are the Advantages of Using CGH?

Partnered Content Networks

Relevant Topics